Follow
Alankrita Taneja
Alankrita Taneja
Internal medicine resident
Verified email at nih.gov
Title
Cited by
Cited by
Year
Chronic lymphocytic leukemia
SKR Mukkamalla, A Taneja, D Malipeddi, SR Master
362017
CAR‐T‐OPENIA: Chimeric antigen receptor T‐cell therapy‐associated cytopenias
A Taneja, T Jain
EJHaem 3, 32-38, 2022
242022
Primary renal lymphoma: A population‐based analysis using the SEER program (1973‐2015)
A Taneja, V Kumar, AB Chandra
European Journal of Haematology 104 (5), 390-399, 2020
212020
Comparative effectiveness of a web-based patient decision aid for therapeutic options for sickle cell disease: randomized controlled trial
L Krishnamurti, D Ross, C Sinha, T Leong, N Bakshi, N Mittal, ...
Journal of Medical Internet Research 21 (12), e14462, 2019
192019
Uterine transplant: a risk to life or a chance for life?
A Taneja, S Das, SA Hussain, M Madadin, SW Lobo, H Fatima, ...
Science and engineering ethics 25, 635-642, 2019
142019
Hypercalciuria. Stat Pearls [Internet]. Treasure Island (FL)
SW Leslie, A Taneja
Stat Pearls Publishing, 2017
132017
StatPearls
SKR Mukkamalla, A Taneja, D Malipeddi, SR Master
Treasure Island (FL): StatPearls Publishing, 2023
92023
Handbook of Cancer Treatment-Related Symptoms and Toxicities
V Velcheti, SR Punekar
Elsevier Health Sciences, 2021
62021
Bruton Agammaglobulinemia
A Taneja, E Muco, A Chhabra
62017
Treasure Island (FL) StatPearls Publishing; 2021https
CLLMM SKR, A Taneja, D Malipeddi, SR Master
6
Impact of high-dose steroid premedication on the outcome of myeloablative T-cell replete haploidentical peripheral blood stem cell transplant
A Saad, A Taneja, A Di Stasi, R Sarmad, R Kukkamalla, L Costa, ...
Bone Marrow Transplantation 53 (10), 1345-1348, 2018
52018
A review of the current status of lenalidomide maintenance therapy in multiple myeloma in 2022
RK Gupta, A Gupta, J Hillengass, SA Holstein, VJ Suman, A Taneja, ...
Expert review of anticancer therapy 22 (5), 457-469, 2022
42022
Viral infections after allogeneic hematopoietic stem cell transplant
A Taneja, JH Chewning, A Saad
Advances in Cell and Gene Therapy 2 (2), e43, 2019
42019
Richter transformation to Hodgkin lymphoma on Bruton’s tyrosine kinase inhibitor therapy
A Taneja, J Jones, S Pittaluga, I Maric, M Farooqui, IE Ahn, A Wiestner, ...
Leukemia & lymphoma 60 (2), 519-522, 2019
42019
Serum B-cell maturation antigen as a biomarker for chronic lymphocytic leukemia treated with ibrutinib
C Sun, C Soof, A Taneja, SEM Herman, E Cook, K Udd, H Chen, ...
Blood 130, 4031, 2017
32017
Recent trends in surgical management of heart failure in the united states
SD Roy, SS Taduru, A Taneja, D Ramakrishnan, MA Omer, P Baweja
Journal of Cardiac Failure 23 (8), S122, 2017
32017
The age, comorbidities and albumin (ACA) index is independently associated with overall survival in patients with mantle cell lymphoma (MCL)
OS Akhtar, A Anampa-Guzman, MJ Cortese, A Taneja, S Ba Aqeel, ...
Blood 140 (Supplement 1), 5160-5161, 2022
22022
Trends of cardiac transplantation in cardiac amyloidosis in the United States from 2008–2014
SS Taduru, SD Roy, A Taneja, D Ramakrishnan, P Grover, A Samanta, ...
Journal of Cardiac Failure 23 (8), S124, 2017
22017
Imaging measurable (minimal) residual disease in multiple myeloma
M Bhutani, SZ Usmani, A Taneja, O Landgren
Current Radiology Reports 4, 1-11, 2016
22016
A population level analysis of second hematological malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma survivors in the era of targeted therapies
R Mishra, D Dima, SA Kumar, A Mian, A Taneja, R Karna, PF Caimi, ...
Hematological Oncology 41 (5), 884-893, 2023
12023
The system can't perform the operation now. Try again later.
Articles 1–20